"Gilead’s #lenacapavir could transform the fight against #HIV — but only if millions more patients can get it."
South Africa receives first batch of nearly 38,000 doses of new #HIV prevention medicine #Lenacapavir
iol.co.za/news/south-a...
Why test medicines after they arrive in a country? Because heat, transport problems or counterfeit products can affect quality. That’s why regulators test imported drugs such as #lenacapavir before patients receive them. bhekisisa.org/health-news-...
SA is preparing to roll out anti-HIV jab #lenacapavir. But first, labs in Ireland must confirm the medicine is safe and effective before clinics start using it. Find out more from @miamalan in the latest #BhekisisaInYourInbox. mailchi.mp/bhekisisa.or...
A shipment of the new six-monthly #HIV prevention jab, #lenacapavir, has landed in SA. But clinics can’t use it yet. Scientists first test samples to make sure the medicine wasn’t damaged during transport. bhekisisa.org/health-news-...
Gilead's greed knows no limits.
For all the hype, here we go:
About 37k doses arrived in SA in APRIL 2026 via GFATM and Gilead.
YOU READ THAT RIGHT. 37k!
Are we supposed to celebrate this shocking drip feed and rationing, at the epicenter...?!
Outrageous.
Watch this space...
#lenacapavir
SA’s first batch of the twice-a-year #HIV prevention shot, #lenacapavir, has arrived. But before clinics can use it, scientists must test samples to make sure the meds are safe and still work after the long journey to SA. bhekisisa.org/health-news-...
SA’s #lenacapavir has touched down. Before new medicines reach patients, regulators run safety checks. That will take about a month. The country’s roll-out is expected to start in mid to late May. bhekisisa.org/health-news-...
Living with #HIV (including among #LGBT #PLHIV): A new, daily oral tablet that combines two current HIV treatment medications, #bictegravir and #lenacapavir, may be able to replace more HIV treatment regimens for long-term survivors.
outragemag.com/single-daily...
People in conflict and humanitarian settings face some of the highest risks of HIV. Blocking access to #lenacapavir puts lives in danger. Gilead must act.
📖 : frontlineaids.org/lenacapavir-a-potential-game-changer-in-hiv-prevention-what-stands-in-the-way/
Despite public funding helping develop this medicine, neither this drug nor lower-cost generic versions are available to millions of people around the world.
#Gilead #DoctorsWithoutBorders #HIVPrevention #Lenacapavir #PrEP
www.politico.com/newsletters/...
2️⃣ Bislang haben nur wenige der 18 Länder, die im Rahmen einer Vereinbarung zwischen Gilead und dem Globalen Fonds anspruchsberechtigt sind, Kontingente des #HIV- Prophylaxe-Medikaments #Lenacapavir erhalten. Die zugesagte Menge reicht nur für 2 Millionen Menschen über einen Zeitraum von 3 Jahren.
🧵1️⃣ Trotz Aussagen von Gilead Sciences, dass die Produktion von #Lenacapavir zur medizinischen #HIV- Prophylaxe #PrEP bei Bedarf ausgeweitet werden könne, hat das Unternehmen Anfragen von Ärzte ohne Grenzen abgelehnt, eine begrenzte Menge für den Einsatz in deren #HIV- Programmen zu kaufen. /2
When Gilead plays god, after extracting global south participation...
Worse, Gilead cannot meet global demand. That much is clear.
👇🏿
#lenacapavir
@doctorswithoutborders.org hat einen Offenen Brief an das Pharmaunternehmen Gilead veröfffentlicht. Das Unternehmen weigert sich, begrenzte Mengen des #HIV- Medikaments #Lenacapavir, das als 6-Monats-Spritze zur medizinischen HIV-Prophylaxe #PrEP eingesetzt wird, an die NGO zu verkaufen.
"Doctors Without Borders/Médecins Sans Frontières (MSF) calls on Gilead to sell #lenacapavir directly to organizations ready to purchase it, and to take additional concrete steps toward ensuring global access to this breakthrough in HIV prevention."
We're sharing the new #HIV Prevention 2030 Access Framework w/ @unaids.org.
“Innovations...especially #lenacapavir, have added to the array of prevention choices...History will judge us harshly if we as a global community fail to meet this scientific moment," says our ED. Read: tinyurl.com/2rudup69
#Lenacapavir besitzt zur Behandlung von Menschen mit HIV-Infektion und zur HIV-Präexpositionsprophylaxe bereits seit Längerem eine Zulassung. Ausreichend verfügbar ist das wichtige Medikament aber noch nicht. »Ärzte ohne Grenzen« macht jetzt mit einem offenen Brief an Hersteller Gilead Druck.
“That this drug’s development was supported by public funding - and through [...] clinical trials, [...] in countries now excluded from affordable access - makes the current restrictions even more unconscionable.” #MSF #Gilead #Lenacapavir #HIV #PrEP
www.vitalsigns.news/access-denie...
El #lenacapavir ha mostrado una eficacia del 100% en la prevención del #VIH con solo dos inyecciones al año.
Pero el reto no es científico, sino de acceso: llevar esta innovación a quienes más la necesitan.
🟠 efesalud.com/lenacapavir-vih-farmaco-...
#SaludGlobal
Kenya and Zimbabwe are among the first African countries to offer #lenacapavir, a game-changing #HIV prevention injection that's shown 100% efficacy 💉. You only need it twice a year. Kenya is already giving it out free at public clinics 🇰🇪, while Zimbabwe is rolling it out across 24 sites 🇿🇼.
#CAB-LA, the #HIV prevention injection, was approved in SA over three years ago but never reached government clinics. As #lenacapavir prepares to launch, read the lessons CAB-LA carries for public health.
bhekisisa.org/article/2026...
From advancing access to #lenacapavir for #PrEP in Zambia to mobilizing global advocacy for #HIV research and translating science at #CROI2026, see how AVAC's advocacy is driving impact.
Read more: avac.org/blog/the-imp...
After US defunding shocks in 2025, “this year will have to be one of strategic rebuilding”, experts say. Can #lenacapavir roll-out be the answer for SA? We look at what the data says. #EndAids #PrEP bhekisisa.org/health-news-...
Will #SA “do the right thing in its #Aids response this year” to help the world “when #Pepfar wouldn’t”? It depends on how the health department rolls out #lenacapavir. Here’s what models show. bhekisisa.org/health-news-...
Could South Africa slash #HIV infections by three-quarters over the next 20 years? Modelled data say it’s possible — if we roll out enough #lenacapavir.
We break down the data.
bhekisisa.org/health-news-...
Breaking barriers for key populations in the lenacapavir era
This review highlights #lenacapavir as a promising long‑acting #PrEP for #HIV prevention, stressing that success requires tackling inequities, stigma, and access barriers through inclusive, community‑driven, equity‑focused strategies.
#OpenAccess: doi.org/10.1016/j.dc...
In #Nigeria wird die medizinische #HIV- Prophylaxe #PrEP mit der 6-Monats-Spritze mit dem Wirkstoff #Lenacapavir eingeführt. Das Interesse im Land ist offenbar groß, aber es scheint auch das Missverständnis zu geben, es handele sich um eine HIV-Heilung.
Long-Acting HIV Treatments: Fewer Pills, More Freedom? #sexed #AIDS #Health #HIV #Lenacapavir